DIN 02468735 — AKYNZEO 300 MG; 0.5 MG
AKYNZEO is a capsule of Netupitant / Palonosetron marketed by KNIGHT THERAPEUTICS INC.. The full Netupitant / Palonosetron monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02468735
- Brand name
- AKYNZEO
- Active ingredient
- Netupitant / Palonosetron
- Strength
- 300 MG; 0.5 MG
- Dosage form
- CAPSULE
- Route
- ORAL
- Manufacturer
- KNIGHT THERAPEUTICS INC.
- Health Canada status
- MARKETED
- Drug class
- Antiemetic (NK1 receptor antagonist / 5-HT3 receptor antagonist combination)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.